redirect pin user minus plus fax mobile-phone office-phone data envelope globe outlook retail close line-arrow-down solid-triangle-down facebook globe2 google hamburger line-arrow-left solid-triangle-left linkedin wechat play-btn line-arrow-right arrow-right solid-triangle-right search twitter line-arrow-up solid-triangle-up calendar globe-americas globe-apac globe-emea external-link music picture paper pictures play gallery download rss-feed vcard account-loading collection external-link2 internal-link share-link icon-close2

Digital Disruption: Pharmaceuticals and Life Sciences

How innovation is reshaping work, the workforce and the workplace

The pharmaceuticals and life sciences industry is evolving rapidly. At the center of this industry shift is the convergence of the life and physical sciences with engineering, computer science and biotechnology. attracting a new breed of worker to the industry and dramatically changing the type and processes of work.

Across Asia Pacific, this transformation is playing out against a backdrop of increased competition from generic rivals, funding challenges for small market targeted smart drugs and the decline of rainmaker blockbuster drugs. Innovations such as inserting miniature laboratories into the body providing real time data collection via cloud computing are driving major breakthroughs in the development of new drugs.

These changes demand an urgent rethink of traditional workplace and real estate solutions – one that CBRE Research foresees will drive the creation of new kinds of workspaces that bring together diverse fields and expertise as pharmaceuticals companies partner with start-ups, universities and even their competitors. Key trends include:

  • Pharmaceuticals companies investing huge amounts of capital in research and development and therefore the cost of real estate is not a major concern as it appears far cheaper by comparison.
  • Laboratories will be smaller and require people to spend less time in them. Robotics and artificial intelligence will support 24/7 laboratory operations while cloud laboratories can be separated from offices and shared with others.
  • The development of workplaces that support physical and virtual collaboration and the remote operation of laboratories and technology will result in the decline of traditional laboratories.
Digital Disruption: Pharmaceuticals and Life Sciences Report

Contact Us

Dr. Henry Chin
Global Head of Investor Thought Leadership
& Head of Research, APAC
+852 2820 8160
+852 2810 0830
Jonathan Hills
Senior Director, Research
Asia Pacific
+852 2820 2881
+852 2810 0830
Peter Andrew
Executive Director
Asia Pacific
Workplace Strategy
+65 63261677